Skip to content

The European Union Falsified Medicines Directive (FMD) is designed to protect public health by securing the pharmaceutical supply chain against counterfeit medicines. It’s a rigorous set of rules that pharmaceutical companies operating in Europe need to abide by, and at Sharp we can help.

Our comprehensive serialisation service can help you meet the criteria demanded by the FMD by making your products fully traceable and trackable through their supply chain.

We’re able to aggregate serial numbers for up to five levels of packaging in multiple formats, from the cavities of our blister packs through to the pallets they ship in, so you’ll always be able to identify where your products are – and where they came from.

Our latest 250 kW solar installation completed for @Sharp_Services
Keeping 2,000 tonnes of carbon out of the atmosphere and saving Sharp about £1m over the system's lifetime #SolarEnergy #renewables https://t.co/4j8OMJdj5e

Are you attending CPhI North America? Stop by the Sharp stand to learn more about our broad portfolio of commercial pharmaceutical packaging and clinical trial management services. @CPhIWW
#Pharma #ClinicalTrials #Biotech #PharmaceuticalPackaging

The UDG Healthcare CEO Awards winners were awarded their trophies from our CEO Brendan McAtamney at our presentation dinner last night at @PowerscourtHtl. It was a fantastic evening, congratulations to all of our winners and finalists. @AshfieldCM @Sharp_Services #UDGCEOAwards